Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients
This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceabilit...
Saved in:
Published in | Journal of Clinical Biochemistry and Nutrition Vol. 68; no. 1; pp. 95 - 100 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japan
SOCIETY FOR FREE RADICAL RESEARCH JAPAN
01.01.2021
Japan Science and Technology Agency the Society for Free Radical Research Japan |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline (p<0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time (p<0.001), whereas gastroesophageal reflux disease increased (p = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60–74 years old) (p<0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 (p<0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time. |
---|---|
AbstractList | This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline (
0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time (
0.001), whereas gastroesophageal reflux disease increased (
= 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60-74 years old) (
<0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 (
<0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time. This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline ( p< 0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time ( p< 0.001), whereas gastroesophageal reflux disease increased ( p = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60–74 years old) ( p <0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 ( p <0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time. This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline (p<0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time (p<0.001), whereas gastroesophageal reflux disease increased (p = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60–74 years old) (p<0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 (p<0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time. This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper gastrointestinal bleeding was evaluated in the Japan Medical Data Center claims database of 13,019,713 patients aged 20 to 74 years with traceability for 3 months from 2009 to 2014. The incidence was compared with peptic ulcers and gastroesophageal reflux disease. The prescription of medications was also evaluated. The incidence of bleeding was 0.137%, 0.121%, 0.113%, 0.106%, 0.099%, and 0.105% during 2009 to 2014 with a time-dependent decline (p<0.001). Peptic ulcers (>10 times higher than the incidence of bleeding) decreased with time (p<0.001), whereas gastroesophageal reflux disease increased (p = 0.006). Upper gastrointestinal bleeding was higher in male patients and older patients (60–74 years old) (p<0.001 respectively). The prescription rate of antithrombotic medications and proton pump inhibitors increased from 2009 to 2014 (p<0.001 respectively). The incidence of upper gastrointestinal bleeding decreased from 2009 to 2014 in this relatively large-scale real-world database in Japan, concomitant with the decrease in peptic ulcers. The decreased incidence might have been due to changes in the disease structure and therapeutic strategies over time. |
Author | Sakata, Yasuhisa Takagi, Kuniaki Fujimoto, Kazuma Akutagawa, Takashi Sugisaki, Nobuyuki Fujimoto, Shun Node, Koichi Tsuruoka, Nanae Esaki, Motohiro Shimoda, Ryo Iwakiri, Ryuichi Yamanouchi, Kohei Anzai, Keizo Takamori, Ayako |
Author_xml | – sequence: 1 fullname: Fujimoto, Shun organization: Department of Internal Medicine, Faculty of Medicine, Saga University – sequence: 2 fullname: Tsuruoka, Nanae organization: Department of Internal Medicine, Faculty of Medicine, Saga University – sequence: 3 fullname: Esaki, Motohiro organization: Department of Internal Medicine, Faculty of Medicine, Saga University – sequence: 4 fullname: Takamori, Ayako organization: Division of Clinical Research Center, Saga University Hospital – sequence: 5 fullname: Sakata, Yasuhisa organization: Department of Internal Medicine, Faculty of Medicine, Saga University – sequence: 6 fullname: Shimoda, Ryo organization: Department of Internal Medicine, Faculty of Medicine, Saga University – sequence: 7 fullname: Akutagawa, Takashi organization: Department of Internal Medicine, Faculty of Medicine, Saga University – sequence: 8 fullname: Node, Koichi organization: Department of Internal Medicine, Faculty of Medicine, Saga University – sequence: 9 fullname: Anzai, Keizo organization: Department of Internal Medicine, Faculty of Medicine, Saga University – sequence: 10 fullname: Sugisaki, Nobuyuki organization: EA Pharma Co., Ltd – sequence: 11 fullname: Iwakiri, Ryuichi organization: Takeda Pharmaceutical Company, Ltd – sequence: 12 fullname: Takagi, Kuniaki organization: Divison of Gastroenterology, Faculty of Medicine, International University of Health and Welfare – sequence: 13 fullname: Yamanouchi, Kohei organization: Divison of Gastroenterology, Faculty of Medicine, International University of Health and Welfare – sequence: 14 fullname: Fujimoto, Kazuma organization: Divison of Gastroenterology, Faculty of Medicine, International University of Health and Welfare |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33536718$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkU9v1DAQxS1URLeFE3dkiQtSlWLHjuPlUKkq5Z8qcYGzNbFnd71ynGAnlfo1-MQ4bFkBF48176enmXln5CQOEQl5ydml4Eq-3dsuXtas4o14QlZca1Y1TKsTsmJrXleMsfUpOct5z5hUjZLPyKkQjVAt1yvy8z3a4CNSH613GO3yo_M4YqJbyFMafJwwTz5CoF1AdD5uFyTjPabSS2gxTvQBIeV31MEEdNjQaYf0C4wQqQ3g-_xb6CDjInJBex-CHyIFa-d-DjChoyNMvljl5-TpBkLGF4_1nHz_cPvt5lN19_Xj55vru8oqLqeqY86h1lpxLcHpDqxcl06DXDT1Wqmudd2mabAGBgKctVJwzZ1zG6eAqVack6uD7zh3PbpljbKQGZPvIT2YAbz5V4l-Z7bDvWm1LIdcF4M3jwZp-DGXI5neZ4shQMRhzqaWWkklWi0K-vo_dD_Mqdx0oVrZqJbVi-HFgbJpyDnh5jgMZ2bJ2ixZm5qZknWhX_09_5H9E24Brg_APk-wxSMAafI24MFMacOX52B61OwOksEofgFBdMJv |
CitedBy_id | crossref_primary_10_1097_MD_0000000000037274 crossref_primary_10_3748_wjg_v29_i18_2717 crossref_primary_10_1002_jgh3_12666 crossref_primary_10_15829_1560_4071_2021_4635 crossref_primary_10_3164_jcbn_23_111 crossref_primary_10_3164_jcbn_23_82 |
Cites_doi | 10.1111/hel.12597 10.3164/jcbn.19-66 10.3164/jcbn.20-51 10.1111/hel.12329 10.1053/j.gastro.2016.09.006 10.3164/jcbn.18-115 10.1159/000492492 10.1159/000490889 10.1007/s00535-019-01559-9 10.1111/hel.12575 10.1111/j.1523-5378.2007.00488.x 10.1111/j.1443-1661.2008.00825.x 10.1111/apt.12907 10.3164/jcbn.17-142 10.1371/journal.pone.0195164 10.1111/den.13577 10.1159/000498967 10.1007/s12072-019-09939-2 10.1136/gutjnl-2017-315131 10.1007/s00535-011-0429-3 10.7150/ijms.28877 10.1007/s00535-009-0047-5 10.2188/jea.JE20090066 10.1080/00365521.2019.1671487 10.3164/jcbn.20-37 10.1136/gutjnl-2015-311304 10.1007/s00228-006-0171-6 10.1111/hel.12495 10.5056/jnm18001 10.1111/j.1365-2036.2004.02220.x 10.1080/17474124.2017.1270205 10.1159/000484228 10.1007/s00535-018-1483-x 10.1159/000485653 10.1136/gutjnl-2019-319300 10.1111/j.1443-1661.2009.00898.x 10.2169/internalmedicine.3248-19 10.1136/gutjnl-2019-319954 10.1111/den.12639 10.1016/S0016-5107(00)70291-4 10.1136/gutjnl-2020-320705 10.3164/jcbn.17-78 10.1007/s00535-007-2157-2 10.1007/s00535-016-1227-8 10.1111/den.12316 10.1007/s00535-013-0839-5 10.2169/internalmedicine.8669-16 10.1007/s00535-005-1720-y 10.1007/s00535-016-1166-4 10.5604/16652681.1198800 10.1111/hepr.13417 10.1053/j.tvir.2012.07.006 |
ContentType | Journal Article |
Copyright | 2021 JCBN Copyright © 2021 JCBN. 2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2021 JCBN 2021 |
Copyright_xml | – notice: 2021 JCBN – notice: Copyright © 2021 JCBN. – notice: 2021. This work is published under https://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2021 JCBN 2021 |
DBID | NPM AAYXX CITATION 7QL 7QP 7TK 7U9 C1K H94 K9. NAPCQ 7X8 5PM |
DOI | 10.3164/jcbn.20-153 |
DatabaseName | PubMed CrossRef Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef Nursing & Allied Health Premium Virology and AIDS Abstracts Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | PubMed Nursing & Allied Health Premium |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Diet & Clinical Nutrition |
EISSN | 1880-5086 |
EndPage | 100 |
ExternalDocumentID | 10_3164_jcbn_20_153 33536718 article_jcbn_68_1_68_20_153_article_char_en |
Genre | Journal Article |
GeographicLocations | Japan |
GeographicLocations_xml | – name: Japan |
GroupedDBID | --- .GJ 29K 2WC 5GY ACGFO ACPRK ADBBV ADRAZ AENEX AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CS3 D-I DIK DU5 E3Z F5P GX1 HH5 HYE JSF JSH KQ8 M48 O5R O5S OK1 P6G PQEST PQQKQ RJT RPM RZJ TKC TR2 NPM AAYXX CITATION 7QL 7QP 7TK 7U9 C1K H94 K9. NAPCQ 7X8 5PM |
ID | FETCH-LOGICAL-c614t-b0dde8886184ad8bac49dde5e1352966b7dbf55e2a0a3adcc43181dddfd6a0673 |
IEDL.DBID | RPM |
ISSN | 0912-0009 |
IngestDate | Tue Apr 09 21:51:29 EDT 2024 Fri Aug 16 03:47:27 EDT 2024 Thu Oct 10 20:47:06 EDT 2024 Fri Aug 23 01:35:47 EDT 2024 Sat Sep 28 08:39:57 EDT 2024 Wed Apr 05 07:42:58 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | JMDC peptic ulcer gastroesophageal reflux disease proton pump inhibitor antithrombotic |
Language | English |
License | Copyright © 2021 JCBN. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c614t-b0dde8886184ad8bac49dde5e1352966b7dbf55e2a0a3adcc43181dddfd6a0673 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844659/ |
PMID | 33536718 |
PQID | 2474567029 |
PQPubID | 1996339 |
PageCount | 6 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7844659 proquest_miscellaneous_2486463783 proquest_journals_2474567029 crossref_primary_10_3164_jcbn_20_153 pubmed_primary_33536718 jstage_primary_article_jcbn_68_1_68_20_153_article_char_en |
PublicationCentury | 2000 |
PublicationDate | 2021-01-01 |
PublicationDateYYYYMMDD | 2021-01-01 |
PublicationDate_xml | – month: 01 year: 2021 text: 2021-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Japan |
PublicationPlace_xml | – name: Japan – name: Gifu – name: Kyoto, Japan |
PublicationTitle | Journal of Clinical Biochemistry and Nutrition |
PublicationTitleAlternate | J. Clin. Biochem. Nutr. |
PublicationYear | 2021 |
Publisher | SOCIETY FOR FREE RADICAL RESEARCH JAPAN Japan Science and Technology Agency the Society for Free Radical Research Japan |
Publisher_xml | – name: SOCIETY FOR FREE RADICAL RESEARCH JAPAN – name: Japan Science and Technology Agency – name: the Society for Free Radical Research Japan |
References | 24 Takara Y, Endo H, Nakano R, et al. Smoking and drinking did not increase the failure of therapeutic Helicobacter pylori eradication by vonoprazan, clarithromycin, and amoxicillin. Digestion 2019; 99: 172–178. 27 Li M, Oshima T, Horikawa T, et al. Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori. Helicobacter 2018; 23: e12495. 18 Sakamoto C, Sugano K, Ota S, et al. Case-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in Japan. Eur J Clin Pharmacol 2006; 62: 765–772. 51 Kinoshita Y, Ishimura N, Ishihara S. Advantages and disadvantages of long-term proton pump inhibitor use. J Neurogastroenterol Motil 2018; 24: 182–196. 28 Handa O, Naito Y, Osawa M, et al. Nutrients and probiotics: current trends in their use to eradicate Helicobacter pylori. J Clin Biochem Nutr 2020; 67: 26–28. 8 Araki T, Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices from unconventional systemic veins in the absence of gastrorenal shunts. Tech Vasc Interv Radiol 2012; 15: 241–253. 12 Shimoda R, Iwakiri R, Sakata H, et al. Endoscopic hemostasis with metallic hemoclips for iatrogenic Mallory-Weiss tear caused by endoscopic examination. Dig Endosc 2009; 21: 20–23. 23 Suzuki S, Gotoda T, Kusano C, et al. Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan. Gut 2020; 69: 1019–1026. 34 Kakiuchi T, Matsuo M, Endo H, et al. A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report. J Gastroenterol 2019; 54: 699–707. 22 Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol 2018; 53: 354–361. 32 Fujimoto Y, Furusyo N, Toyoda K, Takeoka H, Sawayama Y, Hayashi J. Intrafamilial transmission of Helicobacter pylori among the population of endemic areas in Japan. Helicobacter 2007; 12: 170–176. 46 Yamaguchi M, Iwakiri R, Yamaguchi K, et al. Bleeding and stenosis caused by reflux esophagitis was not common in emergency endoscopic examinations: a retrospective patient chart review at a single institution in Japan. J Gastroenterol 2008; 43: 265–269. 49 Kinoshita Y, Adachi K, Hongo M, Haruma K. Systematic review of the epidemiology of gastroesophageal reflux disease in Japan. J Gastroenterol 2011; 46: 1092–1103. 19 Nakamura S, Watanabe T, Shimada S, et al. Does discontinuation of antithrombotics affect the diagnostic yield of small bowel capsule endoscopy in patients demonstrating obscure gastrointestinal bleeding? J Clin Biochem Nutr 2018; 63: 149–153. 26 Furuta T, Yamade M, Kagami T, et al. Influence of clarithromycin on the bactericidal effect of amoxicillin in patients infected with clarithromycin-resistant strains of H. pylori. Gut 2020. DOI: 10.1136/gutjnl-2020-320705. 7 Tsuruoka N, Iwakiri R, Sakata Y, et al. Questionnaire-based survey on gastrointestinal bleeding and management of antithrombotic agents during endoscopy among Asian countries. Digestion 2018; 97: 97–106. 17 Yamaguchi D, Sakata Y, Tsuruoka N, et al. Characteristics of patients with non-variceal upper gastrointestinal bleeding taking antithrombotic agents. Dig Endosc 2015; 27: 30–36. 13 Sugisaki N, Iwakiri R, Tsuruoka N, et al. A case-control study of the risk of upper gastrointestinal mucosal injuries in patients prescribed concurrent NSAIDs and antithrombotic drugs based on data from the Japanese national claims database of 13 million accumulated patients. J Gastroenterol 2018; 53: 1253–1260. 15 Yokoyama S, Tanaka Y, Nakagita K, Hosomi K, Takada M. Bleeding risk of warfarin and direct oral anticoagulants in younger population: a historical cohort study using a Japanese claims database. Int J Med Sci 2018; 15: 1686–1693. 40 Wakatsuki T, Obara K, Irisawa A, et al. Analysis of prognostic factors in patients with gastric varices after endoscopic treatment. Dig Endosc 2009; 21: 232–238. 42 Tanaka J, Akita T, Ko K, Miura Y, Satake M; Epidemiological Research Group on Viral Hepatitis and its Long-term Course, Ministry of Health, Labour and Welfare of Japan. Countermeasures against viral hepatitis B and C in Japan: an epidemiological point of view. Hepatol Res 2019; 49: 990–1002. 47 Fujimoto K. Review article: prevalence and epidemiology of gastro-oesophageal reflux disease in Japan. Aliment Pharmacol Ther 2004; 20 Suppl 8: 5–8. 5 Jono F, Iida H, Fujita K, et al. Comparison of computed tomography findings with clinical risks factors for endoscopic therapy in upper gastrointestinal bleeding cases. J Clin Biochem Nutr 2019; 65: 138–145. 30 Mukai R, Handa O, Suyama Y, Majima A, Naito Y. Effectiveness of including probiotics to Helicobacter pylori eradication therapies. J Clin Biochem Nutr 2020; 67: 102–104. 37 Iwakiri R, Higuchi K, Kato M, et al. Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin. Aliment Pharmacol Ther 2014; 40: 780–795. 10 Toshikuni N, Takuma Y, Tsutsumi M. Management of gastroesophageal varices in cirrhotic patients: current status and future directions. Ann Hepatol 2016; 15: 314–325. 2 Satoh K, Yoshino J, Akamatsu T, et al. Evidence-based clinical practice guidelines for peptic ulcer disease 2015. J Gastroenterol 2016; 51: 177–194. 31 Mabe K, Kikuchi S, Okuda M, Takamasa M, Kato M, Asaka M. Diagnostic accuracy of urine Helicobacter pylori antibody test in junior and senior high school students in Japan. Helicobacter 2017; 22. DOI: 10.1111/hel.12329. 4 Chan FKL, Goh KL, Reddy N, et al. Management of patients on antithrombotic agents undergoing emergency and elective endoscopy: joint Asian Pacific Association of Gastroenterology (APAGE) and Asian Pacific Society for Digestive Endoscopy (APSDE) practice guidelines. Gut 2018; 67: 405–417. 11 Ootani H, Iwakiri R, Shimoda R, et al. Role of Helicobacter pylori infection and nonsteroidal anti-inflammatory drug use in bleeding peptic ulcers in Japan. J Gastroenterol 2006; 41: 41–46. 36 Uemura N, Sugano K, Hiraishi H, et al.; MAGIC Study Group. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study. J Gastroenterol 2014; 49: 814–824. 53 Sakata Y, Tsuruoka N, Takedomi H, et al. A study on the status of proton pump inhibitor prescriptions using diagnosis procedure combination data in Japan. Digestion 2020; 101: 308–315. 29 Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut 2016; 65: 1439–1446. 21 Okuda M, Lin Y, Wang C, Kakiuchi T, Kikuchi S. Metronidazole for Helicobacter pylori eradication therapy among children and adolescents in Japan: overcoming controversies and concerns. Helicobacter 2019; 24: e12575. 39 Robertson M, Ng J, Abu Shawish W, et al. Risk stratification in acute variceal bleeding: comparison of the AIMS65 score to established upper gastrointestinal bleeding and liver disease severity risk stratification scoring systems in predicting mortality and rebleeding. Dig Endosc 2019. DOI: 10.1111/den.13577. 16 Chang CH, Sakaguchi M, Weil J, Verstraeten T. The incidence of medically-attended notovirus gastroenteritis in Japan: modelling using a medical care insurance claims database. PLoS One 2018; 13: e0195164. 33 Tanaka Y, Sakata Y, Hara M, et al. Risk factors for Helicobacter pylori infection and endoscopic reflux esophagitis in healthy young Japanese volunteers. Intern Med 2017; 56: 2979–2983. 9 Iwamoto J, Murakami M, Monma T, et al. Current status of prevention of drug-induced gastroduodenal ulcer in real practice: a cross-sectional study. J Clin Biochem Nutr 2020; 66: 158–162. 41 Iwakiri R, Koyama T, Hirano M, et al. Endoscopic injection sclerotherapy for esophageal varices prolonged survival of patients with hepatocellular carcinoma complicating liver cirrhosis. Gastrointest Endosc 2000; 51: 569–572. 38 Szeto CC, Sugano K, Wang JG, et al. Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations. Gut 2020; 69: 617–629. 6 Matsuura S, Sakata Y, Tsuruoka N, et al. Outcomes of patients undergoing endoscopic hemostasis for the upper gastrointestinal bleeding were not influenced by the timing of hospital emergency visits: a situation prevailing in Japan. Digestion 2018; 97: 260–266. 20 Kato M, Ota H, Okuda M, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2016 Revised Edition. Helicobacter 2019; 24: e12597. 52 Takagi T, Naito Y, Inoue R, et al. The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study. J Clin Biochem Nutr 2018; 62: 100–105. 14 Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. J Epidemiol 2010; 20: 413–419. 25 Harada A, Kurahara K, Moriyama T, et al. Risk factors for reflux esophagitis after eradication of Helicobacter pylori. Scand J Gastroenterol 2019; 54: 1183–1188. 45 Ide T, Koga H, Nakano M, et al. Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study. Hepatol Int 2019; 13: 293–301. 43 Isoda H, Oeda S, Takamori A, et al. Generation gap for screening and treatment of hepatitis C virus in Saga prefecture, Japan: an administrative database study of 35,625 subjects. Intern Med 2020; 59: 169–174. 44 Hayes CN, Imamura M, Chayama 44 45 46 47 48 49 50 51 52 53 10 11 12 13 14 15 16 17 18 19 1 2 3 4 5 6 7 8 9 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 |
References_xml | – ident: 20 doi: 10.1111/hel.12597 – ident: 9 doi: 10.3164/jcbn.19-66 – ident: 28 doi: 10.3164/jcbn.20-51 – ident: 31 doi: 10.1111/hel.12329 – ident: 35 doi: 10.1053/j.gastro.2016.09.006 – ident: 5 doi: 10.3164/jcbn.18-115 – ident: 3 doi: 10.1159/000492492 – ident: 24 doi: 10.1159/000490889 – ident: 34 doi: 10.1007/s00535-019-01559-9 – ident: 21 doi: 10.1111/hel.12575 – ident: 32 doi: 10.1111/j.1523-5378.2007.00488.x – ident: 12 doi: 10.1111/j.1443-1661.2008.00825.x – ident: 37 doi: 10.1111/apt.12907 – ident: 19 doi: 10.3164/jcbn.17-142 – ident: 16 doi: 10.1371/journal.pone.0195164 – ident: 39 doi: 10.1111/den.13577 – ident: 53 doi: 10.1159/000498967 – ident: 22 – ident: 45 doi: 10.1007/s12072-019-09939-2 – ident: 4 doi: 10.1136/gutjnl-2017-315131 – ident: 49 doi: 10.1007/s00535-011-0429-3 – ident: 15 doi: 10.7150/ijms.28877 – ident: 48 doi: 10.1007/s00535-009-0047-5 – ident: 14 doi: 10.2188/jea.JE20090066 – ident: 25 doi: 10.1080/00365521.2019.1671487 – ident: 30 doi: 10.3164/jcbn.20-37 – ident: 29 doi: 10.1136/gutjnl-2015-311304 – ident: 18 doi: 10.1007/s00228-006-0171-6 – ident: 27 doi: 10.1111/hel.12495 – ident: 51 doi: 10.5056/jnm18001 – ident: 47 doi: 10.1111/j.1365-2036.2004.02220.x – ident: 44 doi: 10.1080/17474124.2017.1270205 – ident: 7 doi: 10.1159/000484228 – ident: 13 doi: 10.1007/s00535-018-1483-x – ident: 6 doi: 10.1159/000485653 – ident: 38 doi: 10.1136/gutjnl-2019-319300 – ident: 40 doi: 10.1111/j.1443-1661.2009.00898.x – ident: 43 doi: 10.2169/internalmedicine.3248-19 – ident: 23 doi: 10.1136/gutjnl-2019-319954 – ident: 1 doi: 10.1111/den.12639 – ident: 41 doi: 10.1016/S0016-5107(00)70291-4 – ident: 26 doi: 10.1136/gutjnl-2020-320705 – ident: 52 doi: 10.3164/jcbn.17-78 – ident: 46 doi: 10.1007/s00535-007-2157-2 – ident: 50 doi: 10.1007/s00535-016-1227-8 – ident: 17 doi: 10.1111/den.12316 – ident: 36 doi: 10.1007/s00535-013-0839-5 – ident: 33 doi: 10.2169/internalmedicine.8669-16 – ident: 11 doi: 10.1007/s00535-005-1720-y – ident: 2 doi: 10.1007/s00535-016-1166-4 – ident: 10 doi: 10.5604/16652681.1198800 – ident: 42 doi: 10.1111/hepr.13417 – ident: 8 doi: 10.1053/j.tvir.2012.07.006 |
SSID | ssj0046564 |
Score | 2.335035 |
Snippet | This study was to examine the recent trends in upper gastrointestinal bleeding in Japan using a large-scale real-world database. The incidence of upper... |
SourceID | pubmedcentral proquest crossref pubmed jstage |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 95 |
SubjectTerms | antithrombotic Bleeding Data centers Evaluation Gastroesophageal reflux gastroesophageal reflux disease JMDC Original peptic ulcer Peptic ulcers proton pump inhibitor Proton pump inhibitors Time dependence Ulcers |
SummonAdditionalLinks | – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9NADLfGQIgXBOMrMJCRJt4Cbe5ySSYhhBjTNIk9UWlv0X1unbq0NKnE_g3-Yux8iU5746WKare5xPbZvvP9DHAgQ9A65CGW2ulYClmwzWWxNqRBIaUIwLZVvmfqZCZPz9PzHRiacfYvsL4zteN-UrP14uPvXzdfyOA_txmnkp-urGEk05iM9x7cTySl6FzDJ8ftBMYEa3GkCq5DoKiiO6h3-8dbrunBFUVnF_6uwPN2_eQ_Dun4CTzuI0n82on-Kez4ag-io7lv8AP2cJ8LPBvQ9vfg4Y9-H_0Z_DnyfCTSI6-0t11F6Qo3q5Vf44Wum_WSYSTI-vkOZtF5OGYhP8qLWEjzJI0Kb8hO6kPkMlNcBqRgEk_J-1ZoF3p-XbcE9pNMnArkFkc0FNTWbq65b5h32AO71s9hdvz957eTuO_OEFty6U1sJjQzUv7MHWO0y422sqBvUj8VvJerTOZMSFOf6IkW2llLoQoFx84FpzS3x3kBu9Wy8q8AtQxC-cw7J-m_8lybwmU5TQ4yJV2aJBEcDIIpVx0IR0nJC8uvZPmVCWUyqYjgsBPayNRbX8ek8nLKHx3zSOPTbTRFRLA_CLoctLBMZEYBZjZJigjej2QyQN5V0ZVfbpgnV1IJGm8ELzu9GO8vRCoUef8Isi2NGRkY3HubUs0vW5DvLGcou-L1_zzTG3iUcAlOu2K0D7vNeuPfUgzVmHetffwFUuciPA priority: 102 providerName: Scholars Portal |
Title | Decline incidence in upper gastrointestinal bleeding in several recent years: data of the Japan claims database of 13 million accumulated patients |
URI | https://www.jstage.jst.go.jp/article/jcbn/68/1/68_20-153/_article/-char/en https://www.ncbi.nlm.nih.gov/pubmed/33536718 https://www.proquest.com/docview/2474567029 https://search.proquest.com/docview/2486463783 https://pubmed.ncbi.nlm.nih.gov/PMC7844659 |
Volume | 68 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Journal of Clinical Biochemistry and Nutrition, 2021, Vol.68(1), pp.95-100 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEB7iUEIupU1fatOyhdCbYlu7q13lVpKGkOLQQgO5iX0pdbBlY8mH_I384s7oRVJ66mURnpG1MDM7M7uz3wAciaIwptBFLIw3seAiI5tTsbGoQYXECMA1Vb5X6cW1uLyRNzsg-7swTdG-s_PjcrE8Lue_m9rK9dKN-zqx8Y_ZqdIE85WNRzBCBe1T9Hb5JfyvBjMqo5oDjCDaS3kc04LxnbMEeRqjle_DHueSp4q6fTzySM_uMCi7Df-KN_8um3zkh85fwPMugGRf24m-hJ1QHkB0Ng81-8I6lM8Fu-pB9g9gb9Ydn7-Ch7NANyEDow32ppkoPrHteh027NZU9WZF6BFo9PQFu2gdG7Gg-6S9K4bLI86K3aN5VCeMqkvZqmAYQ7JLdLolcwszX1YNgdwjEaecUWcjnAozzm2X1C4seNbhuVav4fr826_Ti7hryhA79OR1bCe4IGLaTI1ijNfWOJHhLzJMOR3hplZ5W0gZEjMx3HjnMELBmNj7wqeGuuK8gd1yVYZ3wIwoeBpU8F7gf2ltbOaVxjVBSFShSRLBUS-YfN1ib-SYs5AocxJlnmACI3kEJ63QBqZOV1qmVOdTGlrmgUaX2nBliOCwF3TeWW-VJ0JhXKkmSRbB54GMdkeHKaYMqy3x6FSkHOcbwdtWL4bv95oVgXqiMQMDYXo_paCqN9jenWq__-83P8B-QmU3zS7RIezWm234iHFTbT_B6PtPjeNM0Ig28wfSyB7y |
link.rule.ids | 230,315,730,783,787,888,2228,24330,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VgkovPEppDQUWqeLmxPGuX72hliqUJuLQot6sfbmkJE4U2wf4GfxiZvxSW3GBS2RlJrFX_uaxu7PfAByKLJMyizNXSCNdwUVCNhe5UiGCsgAzAF1X-U7D8aU4uwquNiDozsLURftazQb5fDHIZ9_r2srVQg-7OrHh18lxFBPNVzJ8AA_RXj3RTdIbB0wMYDVrVEJVB5hDNMfyOE4MhjdaEempi3a-DVucBzyMqN_HrZj06AbTsmv7t4zzfuHkrUh0-hS-dWNoClB-DKpSDfSve_SO_zzIZ_CkzU3Zx0b8HDZsvgPOycyW7ANrCUTnbNrx9-_A1qTdmX8Bv08sHbK0jNbu6z6leMWq1cqu2bUsyvWSiCnQn9Ad1LyJmaSCkZmWxRh6Xhwu-4mWVxwxKlxly4xhesrOMJ7nTM_lbFHUAoq8JBxxRk2T8FGY1LpaUCcya1hLFVvswuXpp4vjsdv2e3A1Jgmlqzz0tTgjpx400sRKapHgN4EdcdodDlVkVBYE1pee5NJojckPptvGZCaU1HDnJWzmy9zuA5Mi46GNrDEC_yuOpUpMFKO7EQGi0_MdOOzeeLpqaD1SnA4RRlLCSOrj3CjgDhw1aOiV2jfUKIVxOqKPRrmX0Xk5dDoOHHQISlvHUKS-iDBljTw_ceB9L0aTpn0amdtlRTpxKEKOz-vAXgO4_v4dZB2I7kCxVyC68LsSBFhNG94C6tV___IdPB5fTM7T88_TL69h26fqnnox6gA2y3Vl32B6Vqq3tTH-Ad58PyQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB5BQVEvBcqjhgKLVHFzHt71qzfUEJVCox6oVHGx9uWSkjhWbB_gZ_CLmfFLacWpl8jKTmKvPI9vdme_ATgSaSplGqWukEa6gouYbC50pUINSn1EALqu8p0Hp5fi7Mq_2mr1VRfta7UYZsvVMFv8rGsr85UedXVio4vzkzAimq94lJt09BAeoc2Ogy5Rb5wwsYDVzFExVR4gjmiO5nFMDkY3WhHxqYu2vgsDzn0ehNTzYysuPb5BaHZt_4c67xZPbkWj2RP40c2jKUL5NaxKNdR_7lA83muiT2GvxajsUyPyDB7YbB-c6cKW7CNriUSXbN7x-O_D4LzdoX8Of6eWDltaRmv4db9SvGJVntsNu5ZFuVkTQQX6FbqDWjaxk0QwQtPyGEMPjFNmv9ECi2NGBaxsnTKEqewM43rG9FIuVkU9QBGYBiecUfMkfBQmta5W1JHMGtZSxhYv4HL2-fvJqdv2fXA1goXSVWP0uZiZUy8aaSIltYjxG99OOO0SByo0KvV968mx5NJojSAIYbcxqQkkNd55CTvZOrMHwKRIeWBDa4zA_4oiqWITRuh2hI9aOvYcOOreepI39B4JpkWkJwnpSeJhjuRzB44bjeiF2rfUCAVRMqGPRrgfo3Nz6HwcOOy0KGkdRJF4IkToGo692IEP_TCaNu3XyMyuK5KJAhFwfF4HXjVK19-_U1sHwlvq2AsQbfjtEVSymj68VarX9_7lexhcTGfJty_zr29g16Min3pN6hB2yk1l3yJKK9W72h7_AZ-jQaQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Decline+incidence+in+upper+gastrointestinal+bleeding+in+several+recent+years%3A+data+of+the+Japan+claims+database+of+13+million+accumulated+patients&rft.jtitle=Journal+of+Clinical+Biochemistry+and+Nutrition&rft.au=Fujimoto%2C+Shun&rft.au=Tsuruoka%2C+Nanae&rft.au=Esaki%2C+Motohiro&rft.au=Takamori%2C+Ayako&rft.date=2021-01-01&rft.pub=SOCIETY+FOR+FREE+RADICAL+RESEARCH+JAPAN&rft.issn=0912-0009&rft.eissn=1880-5086&rft.volume=68&rft.issue=1&rft.spage=95&rft.epage=100&rft_id=info:doi/10.3164%2Fjcbn.20-153&rft.externalDocID=article_jcbn_68_1_68_20_153_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0912-0009&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0912-0009&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0912-0009&client=summon |